Structural Heart Devices Market to Reach USD 48.2 Billion by 2036, Expanding at 11.2% CAGR on Rising Adoption of Minimally Invasive Cardiac Procedures

According to a recent Fact.MR study, the global Structural Heart Devices Market is set for substantial growth, driven by increasing adoption of minimally invasive cardiac interventions, rising cardiovascular disease prevalence, and expanding investments in advanced cardiac treatment infrastructure.

Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.factmr.com/connectus/sample?flag=S&rep_id=8136

The market was valued at USD 15.0 billion in 2025 and is estimated to reach USD 16.7 billion in 2026. Fact.MR forecasts the market to grow to USD 48.2 billion by 2036, registering a CAGR of 11.2% during the forecast period from 2026 to 2036.

Key Market Highlights

• Market size expected to increase from USD 16.7 billion in 2026 to USD 48.2 billion by 2036
• Forecast CAGR of 11.2% between 2026 and 2036
• Nearly USD 31.5 billion in incremental revenue opportunity anticipated over the next decade
• Transcatheter heart valves to account for approximately 40% market share in 2026
• Replacement procedures expected to hold around 60% share
• Hospitals projected to represent 55% of total demand
• Geriatric patients expected to contribute 50% market share
• Aortic valve stenosis to account for nearly 45% of market demand
• India forecast to be the fastest-growing country with a 13.1% CAGR

Growing preference for catheter-based procedures over conventional open-heart surgeries is significantly improving patient outcomes while reducing hospitalization and recovery times. Increasing reimbursement support and physician acceptance continue to accelerate market adoption globally.

Analyst Viewpoint

"Structural heart device manufacturers are increasing focus on minimally invasive intervention systems and hospital training capability. Reimbursement expansion and physician adoption will shape long-term procedure growth across emerging healthcare markets."

Competitive Landscape

The market remains moderately consolidated, with leading manufacturers focusing on technological innovation, clinical validation, physician education, and hospital partnerships to strengthen their market positions.

Key companies include:

• Abbott Laboratories, Inc.
• Boston Scientific Corporation
• CryoLife, Inc.
• Edwards Lifesciences Corporation
• Medtronic plc

Recent advancements, including approvals for transcatheter valve replacement and repair systems, are reshaping competitive dynamics and expanding treatment options for structural heart disease patients.

Production and Consumption Analysis

Production of structural heart devices is concentrated in major medical technology hubs including the United States, China, Germany, Ireland, and Switzerland, where manufacturers benefit from advanced engineering capabilities and established healthcare ecosystems.

On the consumption side, demand remains strongest in the United States, Germany, Japan, China, and India. Growth is fueled by increasing cardiovascular disease burden, aging populations, and expanding access to advanced cardiac care services.

Supply Chain and Procurement Insights

The structural heart devices value chain spans raw material sourcing, device manufacturing, regulatory approvals, hospital procurement, physician training, and patient treatment.

Key procurement trends include:

• Preference for clinically validated products
• Growing demand for comprehensive physician training programs
• Increased focus on supplier reliability and service support
• Greater emphasis on reimbursement compatibility and procedural efficiency

Healthcare providers increasingly favor manufacturers offering integrated support services alongside advanced device technologies.

Access In-Depth Market Insights and Trends: https://www.factmr.com/report/structural-heart-devices-market

Regional Opportunity Assessment

India is projected to lead global growth with a 13.1% CAGR, supported by expanding tertiary cardiac care facilities, rising cardiovascular diagnosis rates, and growing adoption of transcatheter procedures.

China is expected to grow at 12.6% CAGR, driven by domestic manufacturing expansion and increasing procedure volumes.

The United States remains the largest revenue-generating market, supported by strong reimbursement coverage and widespread adoption of minimally invasive cardiac interventions.

Technology and Innovation Outlook

Innovation continues to transform the structural heart devices industry through:

• Next-generation transcatheter valve replacement systems
• Advanced valve repair technologies
• AI-assisted procedural planning
• Enhanced imaging and navigation platforms
• Improved biomaterials and device durability
• Digital patient monitoring solutions

Manufacturers investing in minimally invasive technologies and next-generation structural heart therapies are expected to capture significant growth opportunities over the coming decade.

Unlock 360° insights for strategic decision making and investment planning: https://www.factmr.com/checkout/8136

Explore In-Depth Healthcare Market Insights: https://www.factmr.com/industry/healthcare

To View Related Report:

Alpha Emitters Market https://www.factmr.com/report/alpha-emitters-market
Venipuncture Procedure Market https://www.factmr.com/report/venipuncture-procedure-market
Autopsy Tables Market https://www.factmr.com/report/autopsy-tables-market
Air Ambulance Services Market https://www.factmr.com/report/air-ambulance-services-market

- Contact Us -
11140 Rockville Pike, Suite 400, Rockville,
MD 20852, United States
Tel: +1 (628) 251-1583 | sales@factmr.com

About Fact.MR

Fact.MR is a global market research and consulting firm, trusted by Fortune 500 companies and emerging businesses for reliable insights and strategic intelligence. With a presence across the U.S., UK, India, and Dubai, we deliver data-driven research and tailored consulting solutions across 30+ industries and 1,000+ markets. Backed by deep expertise and advanced analytics, Fact.MR helps organizations uncover opportunities, reduce risks, and make informed decisions for sustainable growth.

This release was published on openPR.